Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Compounded by a state licensed pharmacy
Injection Sites and Rotation Subcutaneous injection sites for CJC-1295: Abdomen: Most common
Whilst these compounds have established biochemical functions, there is no robust randomised controlled trial evidence for clinically meaningful weight loss or fat reduction in replete individuals
Stable Gastric Pentadecapeptide BPC 157 research protocol for Primary Abdominal [PMID: 34966273] Laboratory literature summary: Stable Gastric Pentadecapeptide BPC 157 research protocol for Primary Abdominal Compartment Syndrome in Rats
But since I never dropped back to the massive levels of fatigue I was previously feeling, I havent felt it was something to continue using since those ended
In the UK, BPC-157 is not a licensed medicine and has no marketing authorisation
